Stem Cells News
-
Stem cells taken from human ovaries were used to produce early-stage eggs by scientists in Boston who may have created a new method to help infertile women.
-
Veronique Pittman, wife of CC Media Holdings Inc.’s chief executive officer, Robert Pittman, and a trustee at the Green Schools Alliance, recommended the pickled string beans.
-
Stem cells grown from patients’ own cardiac tissue can heal damage once thought to be permanent after a heart attack, according to a study that suggests the experimental approach may one day help stave off heart failure.
-
Advanced Cell Technology Inc., the second company to win permission from the U.S. to test embryonic stem cells in people, rose the most in a year after it reported the cells improved vision in two patients.
-
U.K. Chancellor of the Exchequer George Osborne backed joint scientific research projects into stem cells and green energy with China as he sought to forge links with companies in the world’s fastest growing economy.
-
Researchers have created embryonic stem cells using human eggs for the first time, a feat that may bring scientists one step closer to treatments that can be devised from a patient’s own cells.
-
Bristol-Myers Squibb Co. and Sanofi won an appeals court ruling that upholds a $442 million patent- infringement judgment against Apotex Inc. related to generic copies of the blood thinner Plavix.
-
Six months ago, Roche Holding AG scientists disrupted the rhythmic beating of heart muscle made from stem cells by adding a cancer drug to it, duplicating in the laboratory a side effect previously only seen in patients.
-
Last week, with the announcement that scientists had created stem cells, not from embryos, but from adult cells, one controversy in biomedicine was replaced by another. No sooner had the problem of using human embryos been solved than a problem with selling human eggs sprang up. Let’s take these one at a time.
-
Potent stem cells derived from reprogramming skin or other adult body tissues may have limits on their usefulness as an alternative to cells from human embryos, researchers said.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page